Will Medicare Cover Insulin?

For decades, insulin costs have been a source of anxiety for Medicare beneficiaries living with diabetes. While Medicare had covered insulin in certain situations for years, many people still faced steep monthly bills. That changed in 2023, when the Inflation Reduction Act’s insulin cap took effect: on January 1, 2023, for Part D, and on July 1, 2023, for Part B insulin used with a traditional pump. The cap applies all year long, even during the coverage gap (the “donut hole”), and is calculated separately for each covered insulin product.

Today, most Medicare patients pay no more than $35 per month for their insulin, whether it’s delivered through a vial and syringe, an insulin pen, or certain insulin pumps. For the more than 3 million Medicare Part D enrollees who use insulin, the change has eased financial strain and made it easier to stick with treatment. The exact rules still depend on your delivery method, plan type, and whether your insulin is included in your plan’s formulary.

Medicare Insulin Coverage Basics

Medicare’s insulin benefits are split across different parts of the program, and the way your insulin is delivered determines which part applies. Understanding these distinctions is the first step to knowing exactly how your coverage works.

How Medicare Covers Insulin

Medicare coverage depends largely on the delivery method:

• Under the Inflation Reduction Act, all covered insulin under both parts is subject to a $35 monthly cap for a one-month supply of each covered insulin product.
• Part B covers insulin when used with a Medicare-approved insulin pump classified as durable medical equipment. The $35 monthly cap applies only to insulin used with a covered pump.
• Part D, through standalone Medicare Part D plans or Medicare Advantage plans with drug coverage, covers most insulin obtained from a retail pharmacy, including vials, pens, cartridges, and inhaled products like Afrezza. Disposable patch pumps such as Omnipod are also covered under Part D if your plan covers them, but the pump itself isn’t subject to the $35 cap and may have separate costs, deductibles, or prior authorization rules.

Because the cap applies year-round under Part D, even during the coverage gap, beneficiaries can better predict their monthly insulin costs and avoid unexpected spikes.

Medicare Part B vs Part D Insulin Coverage

For insulin used with a Medicare-covered durable pump, Part B coverage is capped at $35 per month for each covered insulin product, and the Part B deductible doesn’t apply.

Part D coverage follows your plan’s copay or coinsurance rules but applies the $35 maximum in every phase of the plan year. Some beneficiaries may have insulin covered under both parts, typically when they use more than one delivery method, such as pump insulin billed under Part B and pen or vial insulin billed under Part D.

Medicare Advantage plans must provide these same insulin cost protections, meaning patients in private plans pay no more than $35 for a one-month supply of covered insulin.

Medicare Insulin Approval Requirements

Before Medicare will cover your insulin, you must meet certain medical and administrative criteria. These rules help confirm that insulin therapy is medically appropriate and that the prescribed type and dosage fit your health needs.

Medical Necessity Requirements

To qualify for Medicare-covered insulin, you must have a documented diabetes diagnosis and a prescription from a qualified provider. Supporting records may include:

• Blood glucose monitoring results and HbA1c levels.
• Treatment history showing how your condition has been managed to date.
• In some cases, plan-required documentation such as prior authorization, step therapy, or quantity limit exceptions.

Ongoing coverage may also depend on your plan’s rules and continued medical documentation, especially for insulin covered under Part B or for drugs subject to Part D coverage rules.

Prescription and Documentation Process

Once insulin is prescribed, your provider will specify the exact type, dosage, frequency, and delivery method. From there, you or your provider should confirm that the insulin is on your plan’s formulary and check whether the plan requires prior authorization, step therapy, or quantity limits. Plans may also have refill timing rules, which you’ll need to follow to avoid interruptions. While lower-cost options are often encouraged, you can request coverage for a brand-name or higher-cost product if your prescriber submits supporting medical documentation.

Medicare-Covered Insulin Types and Diabetes Supplies

Medicare covers more than the insulin itself. It also covers some of the supplies and devices used in daily diabetes management. Knowing which benefits fall under Part B versus Part D can help you avoid surprise charges.

Insulin Types and Delivery Methods

Most self-administered prescription insulin, including vials, pens, and cartridges, falls under Part D. Insulin for use with a Medicare-covered pump is billed under Part B. Some beneficiaries may also qualify for coverage of continuous glucose monitors, including related supplies, if they meet Medicare’s eligibility rules. This broader coverage can help patients get both the medication and some of the tools used for diabetes management.

Medicare Diabetes Management Supplies

Managing diabetes safely requires consistent access to monitoring equipment and emergency resources. Medicare supports this through coverage for:

• Blood glucose meters and matching test strips, in amounts tied to your prescribed testing needs and Medicare’s coverage rules.
• DSMT (Diabetes Self-Management Training) programs that teach effective care and prevention strategies.
• Prescription glucagon products when prescribed, if the product appears on your plan’s formulary.

These benefits work alongside insulin coverage to make daily blood sugar management more reliable and less financially stressful.

Medicare Insulin Costs and $35 Cap

The biggest shift in insulin affordability for Medicare beneficiaries came with the $35 monthly maximum, introduced under the Inflation Reduction Act. This cap applies separately to each covered insulin product and remains in place all year under Part D, including during the “donut hole” coverage gap. For many, it has lowered out-of-pocket costs and made it easier to stay on treatment.

2026 Medicare Insulin Costs

Under Part B, insulin used with a Medicare-covered pump is normally subject to 20% coinsurance, but your cost is capped at $35 per month for each covered insulin product, and the Part B deductible does not apply. Other Part B services and supplies still require meeting the annual deductible, currently $283, before the standard 20% coinsurance applies.

Part D and Medicare Advantage (Part C) drug plans apply the $35 cap to most pharmacy-dispensed covered insulin throughout the year, regardless of coverage phase. This consistent cost-sharing structure means beneficiaries aren’t hit with surprise increases midway through the year, even if they use more than one covered insulin product.

The cap has also made it easier for people to plan their healthcare budgets. Before 2023, insulin users often saw their costs climb unpredictably during the coverage gap. Now, cost differences are more likely to be tied to plan premiums, formulary rules, how a prescription is filled, or other covered drugs.

Medicare Insulin Compliance and Monitoring Requirements

Keeping insulin coverage active may require more than just filling a prescription. Depending on your plan and how your insulin is covered, you may need to:

• Have regular follow-up with a physician for diabetes management and insulin dose adjustments.
• Keep records or other documentation that support medical need or plan requirements.
• Stay within the plan’s formulary or request exceptions for non-covered drugs.

These plan and documentation rules are designed to support safety and cost control. Following plan refill rules and reviewing coverage annually can also help you avoid unexpected denials or higher costs if your plan’s formulary changes.

Common Medicare Insulin Coverage Problems

Even with the $35 cap, some beneficiaries still encounter coverage and access issues that can complicate insulin use. These can range from formulary restrictions to pharmacy access issues, and knowing about them ahead of time can help you avoid gaps in treatment.

Coverage and Access Issues

Many plans limit coverage to preferred brands or require prior authorization for certain covered insulin products. Some also restrict which pharmacies you can use for covered prescriptions. For those switching Medicare plans, there’s also the challenge of confirming that current prescriptions will still be covered after the transition.

Cost and Financial Concerns

The $35 cap has eased much of the financial burden, but some costs remain, especially for people using multiple covered insulin products or additional diabetes medications. Beneficiaries can reduce out-of-pocket expenses by exploring:

• Supplemental coverage options, such as Medigap policies, may help with Part B insulin cost-sharing for people in Original Medicare.
• Low-income assistance programs like Extra Help, which can further reduce drug plan premiums and copays.
• Manufacturer patient assistance programs may be available in limited cases, but eligibility for people with Medicare is often restricted and varies by program.

These resources, along with Medicare’s protections, can create a more predictable cost structure, but they still require proactive planning to get the most benefit.

How Solace Can Help with Medicare Insulin Coverage

Medicare’s insulin coverage rules are far better than they once were, but they’re still complex, especially when factoring in formularies, prior authorizations, and plan changes. Solace advocates work directly with patients to untangle these details, helping you get the right insulin at the lowest available cost under your coverage.

Insurance Navigation and Optimization

Advocates can identify the Medicare Part D or Medicare Advantage drug plan that best fits your insulin needs. This often involves:

• Comparing formularies to confirm your prescribed insulin is covered.
• Managing prior authorization or exception requests for specific brands or delivery methods.
• Coordinating benefits if you have supplemental or secondary coverage.

This kind of targeted guidance can help you avoid overpaying or getting stuck in a plan that limits your access to the insulin you need.

Access and Compliance Support

Once your coverage is set, Solace can help keep it running smoothly. Advocates coordinate with doctors and pharmacies to arrange timely refills, set up supply deliveries, and troubleshoot problems like delayed shipments. They can also connect you with insulin access resources and assistance options, such as getinsulin.org, manufacturer patient assistance programs like Lilly Cares Foundation, and directories like RxAssist, depending on your situation and eligibility.

By having someone track your prescriptions, delivery schedules, and insurance rules, you’re less likely to face last-minute shortages or unexpected denials.

Frequently Asked Questions About Medicare Insulin Coverage

Does Medicare cover all types of insulin?

Medicare covers many insulin products, but not every product is covered by every plan. Covered insulin is subject to the $35 monthly cap for each covered insulin product. Coverage still depends on whether the product is covered under Part B or listed on your plan’s formulary.

What if my insulin isn’t on my plan’s formulary?

Each plan’s formulary must cover a wide range of drugs, but it might not include your specific insulin. In most cases, a similar drug should be available. If your prescribed insulin isn’t covered, you can request a formulary exception, supported by medical documentation from your provider.

Can I get a 90-day supply of insulin?

Many Part D plans allow 90-day refills. The $35 monthly limit still applies, which could mean $105 for a 3-month supply. Some plans may offer mail-order options for these larger refills, which can be more convenient for ongoing use.

What happens if I need multiple types of insulin?

The $35 limit applies separately to each covered insulin product, so you may pay $35 per month for each one. For example, if you use more than one covered insulin product, each will have its own $35 cap.

Is insulin covered during the Medicare Part D coverage gap?

Starting in 2025, Medicare Part D no longer has a coverage gap phase. Covered insulin still costs no more than $35 for a one-month supply of each covered insulin product under Part D.

Do I need prior authorization for insulin?

Plans may require prior authorization, step therapy, or quantity limits for certain covered insulin products. If your prescribed insulin isn’t on the plan’s list, you can request an exception with medical documentation from your provider.

What if I use an insulin pump?

If you use a Medicare-covered durable insulin pump, insulin is covered under Part B. If you use certain other pumps, such as disposable patch pumps, insulin may be covered under Part D. If it’s billed under Part B, the $35 monthly cap applies, and the Part B deductible does not apply to the insulin itself.

Are diabetes testing supplies covered separately?

Yes. Meters, test strips, and lancets are covered as separate benefits under Part B, with their own cost-sharing rules. After the Part B deductible, you generally pay 20% of the Medicare-approved amount. By combining Medicare’s $35 monthly cap with the right plan selection, careful documentation, and Solace advocate support, many beneficiaries can keep insulin costs more predictable and access more consistent.

This article is for informational purposes only and does not replace medical advice. Information is subject to change. For medical guidance, consult your healthcare provider.

‍